Deutsch English Français

Contact

EP1399572

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP1399572

EP1399572 - GENE EXPRESSION AND PRODUCTION OF TGF-B PROTEINS INCLUDING BIOACTIVE MULLERIAN INHIBITING SUBSTANCE FROM PLANTS [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 16.12.2011 Database last updated on 30.10.2024
Most recent event Tooltip	16.12.2011	Application deemed to be withdrawn	published on 18.01.2012 [2012/03]
Applicant(s)	For all designated states Oishi, Karen K. 6112 East Lee Highway Draper, VA 24324 / US
	[2004/13]
Inventor(s)	01 / OISHI, Karen, K. 6112 East Lee Highway Draper, VA 24324 / US
	02 / COMARATTA, Leonard, M. 700 McBryde Drive Blacksburg, VA 24060 / US
	[2004/13]
Representative(s)	Dohmen, Johannes Maria Gerardus, et al Algemeen Octrooi- en Merkenbureau P.O. Box 645 5600 AP Eindhoven / NL
	[N/P]
Former [2004/13]	Dohmen, Johannes Maria Gerardus, et al Algemeen Octrooi- en Merkenbureau P.O. Box 645 5600 AP Eindhoven / NL
Application number, filing date	02739690.2	05.06.2002
	[2004/13]
	WO2002US17737
Priority number, date	US20010295545P	05.06.2001 Original published format: US 295545 P
	[2004/13]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	WO02099067
	Date:	12.12.2002
	Language:	EN
	[2002/50]
	Type:	A2 Application without search report
	No.:	EP1399572
	Date:	24.03.2004
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 12.12.2002 takes the place of the publication of the European patent application.
	[2004/13]
Search report(s)	International search report - published on:	US	20.03.2003
	(Supplementary) European search report - dispatched on:	EP	30.12.2004
Classification	IPC:	C12N15/82, C07K14/495, C07K14/575, C12N15/12	[2005/05]
	CPC:	C12N15/8257 (EP,US); C07K14/495 (EP,US)
	Former IPC [2004/13]	C12N15/82, C12N15/10, C12N15/12, A01H5/00
Designated contracting states	AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2004/13]
Extension states	AL	Not yet paid
	LT	Not yet paid
	LV	Not yet paid
	MK	Not yet paid
	RO	Not yet paid
	SI	Not yet paid
Title	German:	GENEXPRESSION UND PRODUKTION VON TGF-B-PROTEINEN EINSCHLIESSLICH DER BIOAKTIVEN MÜLLERSCHEN INHIBIERENDEN SUBSTANZ AUS PFLANZEN	[2004/13]
	English:	GENE EXPRESSION AND PRODUCTION OF TGF-B PROTEINS INCLUDING BIOACTIVE MULLERIAN INHIBITING SUBSTANCE FROM PLANTS	[2004/13]
	French:	EXPRESSION GENIQUE ET PRODUCTION DE PROTEINES TGF-B COMPRENANT UNE SUBSTANCE INHIBITRICE MULLERIENNE BIOACTIVE ISSUE DE VEGETAUX	[2004/13]
Entry into regional phase	05.12.2003	National basic fee paid
	05.12.2003	Search fee paid
	05.12.2003	Designation fee(s) paid
	05.12.2003	Examination fee paid
Examination procedure	21.12.2002	Request for preliminary examination filed International Preliminary Examining Authority: US
	05.12.2003	Examination requested [2004/13]
	23.08.2006	Despatch of a communication from the examining division (Time limit: M06)
	27.02.2007	Reply to a communication from the examining division
	19.04.2007	Despatch of a communication from the examining division (Time limit: M04)
	12.04.2010	Reply to a communication from the examining division
	20.01.2011	Despatch of a communication from the examining division (Time limit: M06)
	02.08.2011	Application deemed to be withdrawn, date of legal effect [2012/03]
	02.09.2011	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2012/03]
Divisional application(s)	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 23.08.2006
Request for further processing for:	The application is deemed to be withdrawn due to failure to reply to the examination report
	12.04.2010	Request for further processing filed
	12.04.2010	Full payment received (date of receipt of payment)
Fees paid	Renewal fee
	29.06.2004	Renewal fee patent year 03
	13.12.2005	Renewal fee patent year 04
	12.06.2006	Renewal fee patent year 05
	14.06.2007	Renewal fee patent year 06
	23.12.2008	Renewal fee patent year 07
	30.12.2009	Renewal fee patent year 08
	25.06.2010	Renewal fee patent year 09
	Penalty fee
	Additional fee for renewal fee
	30.06.2005	04 M06 Fee paid on 13.12.2005
	30.06.2008	07 M06 Fee paid on 23.12.2008
	30.06.2009	08 M06 Fee paid on 30.12.2009
	30.06.2011	10 M06 Not yet paid
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[X]EP0221761 (BIOGEN NV [NL], et al) [X] 1-40 * claims 10-13 *;
		[X]WO8906695 (BIOGEN INC [US]) [X] 1-40 * page 9, line 30 - page 10, line 6; claim 19 * * page 13, line 31 - page 14, line 7 *;
		[X]WO0129242 (MONSANTO CO [US]) [X] 1-4,7-40 * claim 10 *;
		[A] - FAIRLIE W D ET AL, "Expression of a TGF-beta superfamily protein, macrophage inhibitory cytokine-1, in the yeast Pichia pastoris", GENE, ELSEVIER BIOMEDICAL PRESS. AMSTERDAM, NL, (20000822), vol. 254, no. 1-2, ISSN 0378-1119, pages 67 - 76, XP004208782 [A] 1-40 * the whole document * DOI: http://dx.doi.org/10.1016/S0378-1119(00)00295-X
		[A] - KURIAN M S ET AL, "Cleavage of Müllerian inhibiting substance activates antiproliferative effects in vivo.", CLINICAL CANCER RESEARCH : AN OFFICIAL JOURNAL OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH. MAR 1995, (199503), vol. 1, no. 3, ISSN 1078-0432, pages 343 - 349, XP002306941 [A] 1-40 * abstract * * page 347, column 2, paragraph L - page 348 *
		[A] - STEPHEN ET AL, "Tissue-engineered cells producing complex recombinant proteins inhibit ovarian cancer in vivo", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, (20010313), vol. 98, no. 6, ISSN 0027-8424, pages 3214 - 3219, XP002173985 [A] 1-40 * abstract * DOI: http://dx.doi.org/10.1073/pnas.051625998
		[A] - CATLIN E A ET AL, "Müllerian inhibiting substance: new perspectives and future directions.", MICROSCOPY RESEARCH AND TECHNIQUE. 1 JUN 1993, (19930601), vol. 25, no. 2, ISSN 1059-910X, pages 121 - 133, XP008039222 [A] 1-40 * abstract * DOI: http://dx.doi.org/10.1002/jemt.1070250205
		[A] - ITURRIAGA G ET AL, "ENDOPLASMIC RETICULUM TARGETING AND GLYCOSYLATION OF HYBRID PROTEINS IN TRANSGENIC TOBACCO", PLANT CELL, (1989), vol. 1, no. 3, ISSN 1040-4651, pages 381 - 390, XP002306942 [A] 24,37 * abstract *
		[PX] - TEIXEIRA J ET AL, "Müllerian inhibiting substance: an instructive developmental hormone with diagnostic and possible therapeutic applications.", ENDOCRINE REVIEWS. OCT 2001, (200110), vol. 22, no. 5, ISSN 0163-769X, pages 657 - 674, XP002306943 [PX] 1-40 * page 669, column 1, paragraph D *
	International search	[Y]US5689056 (CRAMER CAROLE LYN [US], et al);
		[Y] - LEE M. ET AL., "Mullerian inhibiting substance: a gonadal hormone with multiple functions", ENDOCR. REV., (199304), vol. 14, no. 2, pages 152 - 164, XP002958203 DOI: http://dx.doi.org/10.1210/er.14.2.152
		[Y] - PALACPAC N. ET AL., "Stable expression of human beta1,4-galactosyltransferase in plant cells modifies N-linked glycosylation patterns", PROC. NATL. ACAD. SCI. USA, (1999), vol. 96, pages 4692 - 4697, XP002136340 DOI: http://dx.doi.org/10.1073/pnas.96.8.4692
		[A] - ZUGMAIER G. ET AL., "Transforming growth factors type beta1 and beta2 are equipotent growth inhibitors of human breast cancer cell lines", JOURNAL OF CELLULAR PHYSIOLOGY, (1989), vol. 141, no. 2, pages 353 - 361, XP002958204 DOI: http://dx.doi.org/10.1002/jcp.1041410217
	Examination	- CRAMER C.L. ET AL, "Bioproduction of human enzymes in transgenic tobacco", ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, NEW YORK, US, (19960525), vol. 792, ISSN 0077-8923, pages 62 - 71, XP000856387 DOI: http://dx.doi.org/10.1111/j.1749-6632.1996.tb32492.x

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 34p